The Role of Neutrophil Extracellular Traps in Early Microthrombosis and Brain Injury After Subarachnoid Hemorrhage in

Xiaoke Hao1,2, Zongwei Zeng1, Liang Liang1

  • 1Department of Neurosurgery, Southwest Hospital, Army Military Medical University (Third Military Medical University), No. 30 Gaotanyan Street, Chongqing, 400038, China.

Insights

Neutrophil extracellular traps (NETs) contribute to microthrombosis after subarachnoid hemorrhage (SAH), worsening early brain injury (EBI). Targeting NETs may offer a novel therapeutic strategy for SAH patients.

Area of Science:

  • Neuroscience
  • Immunology
  • Pathology

Background:

  • Microthrombosis is a key factor in secondary brain injury following subarachnoid hemorrhage (SAH).
  • The precise mechanisms driving microthrombosis in SAH remain incompletely understood.
  • Neutrophil extracellular traps (NETs) are implicated in thrombosis but their role in SAH is unclear.

Purpose of the Study:

  • To investigate the involvement of neutrophil extracellular traps (NETs) in the development of microthrombosis after experimental SAH.
  • To explore NETs as a potential therapeutic target for early brain injury (EBI) following SAH.

Main Methods:

  • Subarachnoid hemorrhage (SAH) was induced in mice using an endovascular perforation model.
  • NET formation was assessed by measuring citrullinated histone H3 (CitH3) levels and co-localization with microthrombi.
  • Neutrophil depletion (anti-Ly6G) and DNase I treatment were employed to inhibit NETs and assess their impact.

Main Results:

  • Elevated CitH3 levels and co-localization with microthrombi were observed in the cerebral cortex post-SAH.
  • Both neutrophil depletion and DNase I treatment significantly reduced NETs, microthrombi, and ameliorated neurological deficits, brain edema, BBB disruption, and neuronal injury.
  • DNase I treatment improved early cortical perfusion and attenuated cerebrospinal fluid (CSF) flow by reducing paravascular microthrombi.

Conclusions:

  • NETs are significantly associated with early microthrombosis in the context of SAH.
  • Inhibition of NETs and associated microthrombi shows therapeutic potential for mitigating early brain injury after SAH.
  • Targeting NETs represents a promising novel therapeutic strategy for SAH.

Related Concept Videos